Skip to content

Acupuncture for diminished ovarian reserve: a multicenter randomized controlled trial

Acupuncture for diminished ovarian reserve: a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006407
Enrollment
Unknown
Registered
2022-08-01
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

control group:sham acupuncture
experimental group:acupuncture

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) aged between 20-40; (2) meet the diagnostic criteria of DOR; (3) have a need for fertility, and intend to have a spontaneous pregnancy or to use an antagonist regimen to promote ovulation in the next IVF cycle evaluated by a reproductive physician; (4) volunteer to participate in the trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) combined with any kind of related diseases that affect conception like congenital developmental abnormalities of reproductive organs, untreated endometrial polyps, untreated uterine infection, etc; (2) combined with polycystic ovarian syndrome (PCOS); (3) combined with untreated hyperprolactinemia, hyperandrogenemia, abnormal thyroid function, chronic adrenal hypofunction, and other metabolic endocrine diseases; (4) combined with severe cardiovascular, cerebrovascular, liver, kidney, malignant tumors, hematopoietic system, and mental diseases; (5) have received acupuncture treatment related to improving fertility in the past three months; (6) expect to receive IVF-ET within 2 months after enrollment.

Design outcomes

Primary

MeasureTime frame
Antral Follicle Count;

Secondary

MeasureTime frame
E2 level on HCG day;Number and rate of 2PN;High-quality embryo rate;Live birth rate;Intima thickness on HCG day;Continuous pregnancy rate;Available embryo rate;Biochemical pregnancy rate;Embryo implantation rate;MII oocytes;SAS score;Level of FSH;Cycle cancellation rate;Level of AMH;Number of follicles = 14mm;Clinical pregnancy rate;Early pregnancy loss rate;

Countries

China

Contacts

Public ContactYigong Fang
fangyigong@163.com13520175177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026